Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Skin and diabetes

R G Sibbald1, S J Landolt, D Toth

  • 1Department of Medicine, University of Toronto, Ontario, Canada.

Endocrinology and Metabolism Clinics of North America
|June 1, 1996
PubMed
Summary

Diabetes mellitus frequently causes skin manifestations, yet the underlying cause remains unclear. Recognizing these skin issues, their treatments, and prognoses can aid patient and caregiver understanding of management options.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biomarkers in rosacea: A systematic review.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Tralokinumab plus topical corticosteroids for the treatment of moderate-to-severe atopic dermatitis: results from the double-blind, randomized, multicentre, placebo-controlled phase III ECZTRA 3 trial.

The British journal of dermatology·2020
Same author

Fecal expression of Escherichia coli lysine decarboxylase (LdcC) is downregulated in E-cadherin negative lobular breast carcinoma.

Physiology international·2020
Same author

Anxiety-associated and separation distress-associated behaviours in Angelman syndrome.

Journal of intellectual disability research : JIDR·2019
Same author

Secukinumab demonstrates high sustained efficacy and a favourable safety profile in patients with moderate-to-severe psoriasis through 5 years of treatment (SCULPTURE Extension Study).

Journal of the European Academy of Dermatology and Venereology : JEADV·2018
Same author

Secukinumab sustains good efficacy and favourable safety in moderate-to-severe psoriasis after up to 3 years of treatment: results from a double-blind extension study.

The British journal of dermatology·2017

Area of Science:

  • Dermatology
  • Endocrinology
  • Pathophysiology

Background:

  • Skin manifestations are highly prevalent in patients with diabetes mellitus.
  • Limited understanding exists regarding the common pathophysiological mechanisms linking diabetes and skin conditions.
  • Existing research lacks controlled studies on this association.

Purpose of the Study:

  • To review and synthesize current knowledge on skin manifestations in diabetes mellitus.
  • To highlight the importance of recognizing these dermatological signs.
  • To provide clarity on treatment and prognosis for patients and caregivers.

Main Methods:

  • Literature review of studies on diabetes-related skin conditions.
  • Analysis of pathophysiological links between diabetes and dermatological issues.
  • Synthesis of information on clinical recognition, treatment, and outcomes.

Main Results:

  • Skin manifestations are nearly universal in diabetes mellitus patients.
  • A common pathophysiological link is yet to be definitively identified.
  • Recognition, treatment, and prognosis information can improve patient understanding.

Conclusions:

  • Diabetes mellitus commonly presents with various skin manifestations.
  • Further research is needed to elucidate the shared pathophysiology.
  • Improved awareness of skin conditions aids in diabetes management and patient care.

Related Experiment Videos